Dr. Baris Gencer obtained his medical degree from Lausanne University Hospital in Geneva, Switzerland and continued his residency and fellowship with postgraduate certifications in internal medicine, cardiology and clinical research. He co-authored more than 80 original scientific or review articles, as well as book chapters in the field of lipids, cardiovascular prevention, quality of care, biomarkers and management of acute coronary syndromes. In 2018, he joined Brigham and Women’s Hospital and the TIMI Study Group as a research fellow. His interests include clinical trials and precision medicine in cardiovascular medicine.
Dr. Kazuma Oyama received his medical degree from Tohoku University, Japan and completed a residency in internal medicine and a fellowship in cardiology at Shonan Kamakura General Hospital. He then received his Ph.D. degree from Tohoku University Graduate School of Medicine. He wrote a Ph.D. thesis regarding perivascular adipose tissue inflammation in patients with coronary artery disease through a translational imaging research. He then engaged in critical care medicine as an assistant professor at Tohoku University Hospital. He is currently a research fellow at the TIMI Study Group and an MPH student at the Harvard School of Public Health. His clinical interests include novel therapeutics in acute coronary syndrome and secondary prevention, genetics for precision medicine and biomarker research.
Dr. Antonio Fagundes, Jr. earned his medical degree from the Federal University of Minas Gerais, Brazil, where he completed a residency in internal medicine. In Sao Paulo, he continued his residency training in cardiology and critical care medicine. He then received his Ph.D. degree from Sao Paulo University (USP). He wrote a Ph.D. thesis studying intra-aortic balloon pump in cardiogenic shock. He then engaged in critical care medicine as an ICU coordinator in Brasilia. He is currently a research fellow at the TIMI Study Group. His clinical interests and research are focused on novel therapeutics in acute coronary syndromes and heart failure, cardiogenic shock, critical care cardiology and biomarker research.